Science Explorer Interactive view Map
Company · Houston · United States

RadioMedix (United States)

radiomedix.comROR OpenAlex
Research works
28
▲ 69% vs 2013–17
Citations
418
15.0 per fractional work
Top-10% rate
21.8%
record average 16.5%
Open access
32%
world 28%

Not ranked overall: RadioMedix (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.65× its world share, 1 worksBiochemistry, Geneti…Neuroscience: 4.14× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.02× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.19× its world share, 0 worksComputer ScienceEngineering: 0.41× its world share, 0 worksEngineeringMaterials Science: 0.71× its world share, 0 worksMaterials ScienceMedicine: 3.48× its world share, 3 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.0×. Every wedge is a field page.

Who are the top researchers at RadioMedix (United States)?

Ranked on the composite score, Izabela Tworowska lead among researchers whose main affiliation is RadioMedix (United States).

  1. 1 Izabela Tworowska United States · #1,537,101 worldwide 10 citations · 23 works
All ranked researchers at RadioMedix (United States)

Which keywords describe research at RadioMedix (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Dosimetry, PET Imaging, Immunotherapy, Cancer Treatment, Radioimmunotherapy, Radiopharmaceuticals and Genetic Mutations.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 27 words, with their numbers
  1. Targeted Therapy7▲ 115×5 topics
  2. Dosimetry5▲ 208×2 topics
  3. Immunotherapy5▲ 28×9 topics
  4. PET Imaging5▲ 86×2 topics
  5. Cancer Treatment5▲ 69×3 topics
  6. Radioimmunotherapy5▲ 423×1 topic
  7. Radiopharmaceuticals5▲ 423×1 topic
  8. Genetic Mutations4▲ 31×3 topics
  9. Cancer3▲ 7.2×5 topics
  10. Survival Analysis3▲ 36×3 topics
  11. Neuroendocrine Tumors2▲ 229×1 topic
  12. Pancreatic Neuroendocrine Tumors2▲ 229×1 topic
  13. Clinical Trials2▲ 14×3 topics
  14. Biomarkers2▲ 13×3 topics
  15. Metastasis2▲ 22×3 topics
  16. Chemotherapy2▲ 9.9×4 topics
  17. Genomic Profiles2▲ 184×1 topic
  18. Small-Cell Lung Cancer2▲ 184×1 topic
  19. ALK2▲ 168×1 topic
  20. Imaging2▲ 15×2 topics
  21. Neuroblastoma2▲ 168×1 topic
  22. Cancer Therapy1▲ 8.2×6 topics
  23. Drug Discovery1▲ 12×3 topics
  24. PET/CT1▲ 65×1 topic
  25. Tumor Microenvironment1▲ 15×4 topics
  26. tumor1▲ 65×1 topic
  27. Tumor Targeting1▲ 35×3 topics

Which research topics does RadioMedix (United States) publish most on?

By volume in 2022–2025: Radiopharmaceutical Chemistry and Applications, Cancer, Lipids, and Metabolism, Neuroendocrine Tumor Research Advances and Lung Cancer Research Studies.

Radiopharmaceutical Chem…0Radiopharmaceutical Chemistry and Applications: 0 fractional worksCancer, Lipids, and Meta…0Cancer, Lipids, and Metabolism: 0 fractional worksNeuroendocrine Tumor Res…0Neuroendocrine Tumor Research Advances: 0 fractional worksLung Cancer Research Stu…0Lung Cancer Research Studies: 0 fractional worksBiomedical and Engineering Education: 0 fractional worksProstate Cancer Treatment and Research: 0 fractional worksRadiation Dose and Imaging0Radiation Dose and Imaging: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksScience, Research, and Medicine: 0 fractional worksPeptidase Inhibition and…0Peptidase Inhibition and Analysis: 0 fractional works
Radiology, Nuclear Medicine and ImagingCancer ResearchEpidemiologyOncology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  2. 2 Cancer, Lipids, and Metabolism Cancer Research 0 works
  3. 3 Neuroendocrine Tumor Research Advances Epidemiology 0 works
  4. 4 Lung Cancer Research Studies Oncology 0 works
  5. 5 Biomedical and Engineering Education Biomedical Engineering 0 works
  6. 6 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works
  7. 7 Radiation Dose and Imaging Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  9. 9 Science, Research, and Medicine Reproductive Medicine 0 works
  10. 10 Peptidase Inhibition and Analysis Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available31.5%not open68.5%

World: 28% of research is openly available.

with international co-authors33.3%domestic only66.7%

World: 19% is written across borders.

How has RadioMedix (United States)'s research output changed?

Output in 2018–2022 was 69% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Houston

All research institutions in Houston

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.